View Archive »
About The Cover
The cover for issue 74 of Oncotarget features Figure 4, "Treatment interruptions and dose modifications," by Jordan, et al.
|
|
Table of Contents
News
|
| It’s a numbers game—densitydependent MMP activity mediates cancer cell migration |
|
https://doi.org/10.18632/oncotarget.26115
|
| 33867-33868 |
Editorial
|
| A 17geneexpression profile to improve prognosis prediction in childhood acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26116
|
| 33869-33870 |
Research Papers
|
| IRS2 deubiquitination by USP9X maintains anchorageindependent cell growth via Erk1/2 activation in prostate carcinoma cell line |
|
https://doi.org/10.18632/oncotarget.26049
|
| 33871-33883 |
|
| The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer’s disease |
|
https://doi.org/10.18632/oncotarget.26057
|
| 33884-33895 |
|
| Inhibition of storeoperated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to antiBclxL strategies through Mcl1 downregulation |
|
https://doi.org/10.18632/oncotarget.26084
|
| 33896-33911 |
|
| Estrogen receptorbeta is a potential target for triple negative breast cancer treatment |
|
https://doi.org/10.18632/oncotarget.26089
|
| 33912-33930 |
|
| Isolation of cancer cells with augmented spheroidforming capability using a novel tool equipped with removable filter |
|
https://doi.org/10.18632/oncotarget.26092
|
| 33931-33946 |
|
| Hepatitis B virus promotes βcateninsignalling and disassembly of adherens junctions in a Src kinase dependent fashion |
|
https://doi.org/10.18632/oncotarget.26103
|
| 33947-33960 |
|
| Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents |
|
https://doi.org/10.18632/oncotarget.26104
|
| 33961-33971 |
|
| Inhibitory effects of pentoxifylline on inflammationrelated tumorigenesis in rat colon |
|
https://doi.org/10.18632/oncotarget.26119
|
| 33972-33981 |
|
| Sulforaphane inhibits growth and blocks Wnt/βcatenin signaling of colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.26125
|
| 33982-33994 |
|
| Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRASaltered nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26129
|
| 33995-34008 |
|
| Lenalidomide combined with lowdose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes resulting in immunostimulatory effects in lenalidomiderefractory multiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.26131
|
| 34009-34021 |
Clinical Research Papers
|
| The role of different adjuvant therapies in locally advanced gastric adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26106
|
| 34022-34029 |
Corrections
|
| Correction: p53 and metabolism: from mechanism to therapeutics |
|
https://doi.org/10.18632/oncotarget.26181
|
| 34030-34030 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
